Pegylated interferon alfa-2b (PEG-Intron)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pegylated interferon alfa-2b (PEG-Intron), covering 2017-01-12 to 2017-01-12. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of Pegylated Inferferon Alfa-2b (PEG-Intron™) Versus Pegylated Interferon Alfa-2a (PEGASYS™) in Participants With Chronic Hepatitis B (P08450) [Phase 3]